Gut Hormones Fulfill Their Destiny: From Basic Physiology to the Clinic

Literature Cited

1. Bayliss WM, Starling EH. 1.  1902. The mechanism of pancreatic secretion. J. Physiol. 28:325–53 [Google Scholar]
2. Rehfeld JF. 2.  2012. Beginnings: a reflection on the history of gastrointestinal endocrinology. Regul. Pept. 177:Suppl.1–5 [Google Scholar]
3. Banting FG, Best CH. 3.  1922. The internal secretion of the pancreas. J. Lab. Clin. Med. 7:256–71 [Google Scholar]
4. Bromer WW, Sinn LG, Staub A, Behrens OK. 4.  1957. The amino acid sequence of glucagon. Diabetes 6:234–38 [Google Scholar]
5. Crockford PM, Yakimets WW, Salsberg B, Johnson SA, Joseph P. 5.  1971. Glucagon: a “contaminant” comes of age. Can. Med. Assoc. J. 105:963–68 [Google Scholar]
6. Brazeau P, Vale W, Burgus R, Ling N, Butcher M. 6.  et al. 1973. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77–79 [Google Scholar]
7. Reichlin S. 7.  1986. Somatostatin: historical aspects. Scand. J. Gastroenterol. Suppl. 119:1–10 [Google Scholar]
8. Collip JB. 8.  1925. The extraction of a parathyroid hormone which will prevent or control parathyroid tetany and which regulates the level of blood calcium. J. Biol. Chem. 63:395–438 [Google Scholar]
9. Potts JT. 9.  2005. Parathyroid hormone: past and present. J. Endocrinol. 187:311–25 [Google Scholar]
10. Davidson MB, Bate G, Kirkpatrick P. 10.  2005. Exenatide. Nat. Rev. Drug Discov. 4:713–14 [Google Scholar]
11. Jeppesen PB. 11.  2013. Modern treatment of short bowel syndrome. Curr. Opin. Clin. Nutr. Metab. Care 16:582–87 [Google Scholar]
12. Garin MC, Burns CM, Kaul S, Cappola AR. 12.  2013. Clinical review: the human experience with ghrelin administration. J. Clin. Endocrinol. Metab. 98:1826–37 [Google Scholar]
13. Zac-Varghese S, De Silva A, Bloom SR. 13.  2011. Translational studies on PYY as a novel target in obesity. Curr. Opin. Pharmacol. 11:582–85 [Google Scholar]
14. Ionut V, Bergman RN. 14.  2011. Mechanisms responsible for excess weight loss after bariatric surgery. J. Diabetes Sci. Technol. 5:1263–82 [Google Scholar]
15. Le Roux CW, Borg C, Wallis K, Vincent RP, Bueter M. 15.  et al. 2010. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann. Surg. 252:50–56 [Google Scholar]
16. Chambers AP, Jessen L, Ryan KK, Sisley S, Wilson-Perez HE. 16.  et al. 2011. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 141:950–58 [Google Scholar]